Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dembinski

Showing results (381-390 of 539) with videos related to

Pageof 54
Sort By:
The Lancet. Global Health|July 19, 2024
Receipt of hepatitis E vaccine and fetal loss in rural Bangladesh: further analysis of a double-blind, cluster-randomised, controlled trialAsma Binte Aziz, Susanne Dudman, Cathinka Halle Julin, et al.
Vaccine|January 4, 2023
Immunogenicity and safety of a two-dose regimen with hepatitis E virus vaccine in healthy adults in rural Bangladesh: A randomized, double-blind, controlled, phase 2/pilot trialJoakim Øverbø, Asma Aziz, K Zaman, et al.
Trials|June 3, 2021
Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial : GENIUS-Gelatine use in ICU and sepsisGernot Marx, Kai Zacharowski, Carole Ichai, et al.
The Lancet. Global Health|July 19, 2024
Safety and effectiveness of a recombinant hepatitis E vaccine in women of childbearing age in rural Bangladesh: a phase 4, double-blind, cluster-randomised, controlled trialKhalequ Zaman, Cathinka Halle Julin, Asma Binte Aziz, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 28, 2026
Long-Term Immunity and IgG Subclass Response Following Hepatitis E Vaccination: A Longitudinal Cohort Study in Matlab, BangladeshWarda Haque, Shaumik Islam, Susanne Dudman, et al.
BMJ Open|January 22, 2020
HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural BangladeshK Zaman, Susanne Dudman, Kathrine Stene-Johansen, et al.
BMJ Surgery, Interventions, & Health Technologies|November 10, 2022
Assessing the development status of intraoperative fluorescence imaging for anatomy visualisation, using the IDEAL frameworkTakeaki Ishizawa, Peter McCulloch, Laurents Stassen, et al.
American Journal of Hematology|September 17, 2024
Clearance of pathogenic erythrocytes is maintained despite spleen dysfunction in children with sickle cell diseaseAbdoulaye Sissoko, Astan Cissé, Clémence Duverdier, et al.
Journal of Crohn'S & Colitis|March 26, 2021
Inflammatory Bowel Disease in Patients with Congenital Chloride DiarrhoeaLorenzo Norsa, Roberto Berni Canani, Remi Duclaux-Loras, et al.
Journal of Medical Virology|December 29, 2019
A European multicentre evaluation of detection and typing methods for human enteroviruses and parechoviruses using RNA transcriptsA Hayes, D Nguyen, M Andersson, et al.
Pageof 54

Showing results (381-390 of 539) with videos related to

Sort By:
Pageof 54
The Lancet. Global Health|July 19, 2024
Receipt of hepatitis E vaccine and fetal loss in rural Bangladesh: further analysis of a double-blind, cluster-randomised, controlled trialAsma Binte Aziz, Susanne Dudman, Cathinka Halle Julin, et al.
Vaccine|January 4, 2023
Immunogenicity and safety of a two-dose regimen with hepatitis E virus vaccine in healthy adults in rural Bangladesh: A randomized, double-blind, controlled, phase 2/pilot trialJoakim Øverbø, Asma Aziz, K Zaman, et al.
Trials|June 3, 2021
Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial : GENIUS-Gelatine use in ICU and sepsisGernot Marx, Kai Zacharowski, Carole Ichai, et al.
The Lancet. Global Health|July 19, 2024
Safety and effectiveness of a recombinant hepatitis E vaccine in women of childbearing age in rural Bangladesh: a phase 4, double-blind, cluster-randomised, controlled trialKhalequ Zaman, Cathinka Halle Julin, Asma Binte Aziz, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 28, 2026
Long-Term Immunity and IgG Subclass Response Following Hepatitis E Vaccination: A Longitudinal Cohort Study in Matlab, BangladeshWarda Haque, Shaumik Islam, Susanne Dudman, et al.
BMJ Open|January 22, 2020
HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural BangladeshK Zaman, Susanne Dudman, Kathrine Stene-Johansen, et al.
BMJ Surgery, Interventions, & Health Technologies|November 10, 2022
Assessing the development status of intraoperative fluorescence imaging for anatomy visualisation, using the IDEAL frameworkTakeaki Ishizawa, Peter McCulloch, Laurents Stassen, et al.
American Journal of Hematology|September 17, 2024
Clearance of pathogenic erythrocytes is maintained despite spleen dysfunction in children with sickle cell diseaseAbdoulaye Sissoko, Astan Cissé, Clémence Duverdier, et al.
Journal of Crohn'S & Colitis|March 26, 2021
Inflammatory Bowel Disease in Patients with Congenital Chloride DiarrhoeaLorenzo Norsa, Roberto Berni Canani, Remi Duclaux-Loras, et al.
Journal of Medical Virology|December 29, 2019
A European multicentre evaluation of detection and typing methods for human enteroviruses and parechoviruses using RNA transcriptsA Hayes, D Nguyen, M Andersson, et al.
Pageof 54